UK guidance advises against combining Januvia (a DPP-4 inhibitor) and Rybelsus (a GLP-1 receptor agonist) because they work on related pathways, offering limited additional benefit with poor cost-effectiveness
Modern Nutrition in Health and Disease
Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD
If you have a history of papillary or follicular thyroid cancer , also called differentiated thyroid cancer , current evidence does not show that GLP-1 medications cause or worsen these cancers
Tailoring the dosage or administration of the medication based on individual characteristics could reduce the incidence or severity of side effects
And you were mentioning some people, and you just mentioned now with glutathione how people take IVs and things like that, and it may or may not work for people